Simulations reveal that the HIV-1 gp120-CD4 complex dissociates via complex pathways and is a potential target of the polyamidoamine (PAMAM) dendrimer.
about
A galactose-functionalized dendritic siRNA-nanovector to potentiate hepatitis C inhibition in liver cells.Mechanistic Studies of Viral Entry: An Overview of Dendrimer-Based Microbicides As Entry Inhibitors Against Both HIV and HSV-2 Overlapped Infections."Fusion and binding inhibition" key target for HIV-1 treatment and pre-exposure prophylaxis: targets, drug delivery and nanotechnology approaches.The SPL7013 dendrimer destabilizes the HIV-1 gp120-CD4 complex.Multiple branched adaptive steered molecular dynamics.
P2860
Simulations reveal that the HIV-1 gp120-CD4 complex dissociates via complex pathways and is a potential target of the polyamidoamine (PAMAM) dendrimer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Simulations reveal that the HI ...... yamidoamine (PAMAM) dendrimer.
@en
Simulations reveal that the HI ...... l target of the polyamidoamine
@nl
type
label
Simulations reveal that the HI ...... yamidoamine (PAMAM) dendrimer.
@en
Simulations reveal that the HI ...... l target of the polyamidoamine
@nl
prefLabel
Simulations reveal that the HI ...... yamidoamine (PAMAM) dendrimer.
@en
Simulations reveal that the HI ...... l target of the polyamidoamine
@nl
P2093
P2860
P356
P1476
Simulations reveal that the HI ...... yamidoamine (PAMAM) dendrimer.
@en
P2093
Bidisha Nandy
D Hima Bindu
Narendra M Dixit
Prabal K Maiti
P2860
P304
P356
10.1063/1.4812801
P407
P577
2013-07-01T00:00:00Z